Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INVITAE CORPORATION

(NVTA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/16/2021 09/17/2021 09/20/2021 09/21/2021 09/22/2021 Date
29.74(c) 31.54(c) 30.83(c) 31.79(c) 31.73 Last
2 272 846 5 211 131 2 824 313 4 167 127 1 868 079 Volume
+0.37% +6.05% -2.25% +3.11% -0.19% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 484 M - -
Net income 2021 -530 M - -
Net Debt 2021 342 M - -
P/E ratio 2021 -12,5x
Yield 2021 -
Sales 2022 673 M - -
Net income 2022 -653 M - -
Net Debt 2022 378 M - -
P/E ratio 2022 -10,4x
Yield 2022 -
Capitalization 6 896 M 6 896 M -
EV / Sales 2021 14,9x
EV / Sales 2022 10,8x
Nbr of Employees 2 600
Free-Float 97,0%
More Financials
Company
Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. These tests are delivered through a platform that serves patients, healthcare providers, biopharma companies and other... 
More about the company
Ratings of Invitae Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about INVITAE CORPORATION
09/09VC DAILY : Digital Health Is Booming, but VC Doesn't See a Bubble Forming
DJ
09/07INVITAE : Ciitizen Announcement Conference Call Presentation
PU
09/07INVITAE : — Combination to bring together the power of genomic and clinical informati..
PU
09/07INVITAE CORP : Unregistered Sale of Equity Securities, Regulation FD Disclosure, Other Eve..
AQ
09/07INVITAE : to Acquire Consumer Health Tech Company Ciitizen in $325 Million Deal
MT
09/07INVITAE : to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to ..
PR
09/07Invitae Corporation entered into definitive agreement to acquire Ciitizen Corporation f..
CI
09/01INVITAE : to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
PR
08/19INVITAE : Significant Insider Sales in Shares of Invitae (NVTA) Extends the Selling Trend ..
MT
08/18INSIDER TRENDS : 90-Day Insider Selling Trend Extended at Invitae
MT
08/18INSIDER TRENDS : Invitae Insider Extends 90-Day Selling Trend
MT
08/18INSIDER TRENDS : Invitae Insider Sale Scaling Back 90-Day Buy Trend
MT
08/09INVITAE : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
08/09INVITAE : to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
PR
08/09Global markets live: Alibaba, Citigroup, Tyson Foods, Veoneer, Cisco...
More news
News in other languages on INVITAE CORPORATION
08/19Une importante vente d'initiés sur les actions d'Invitae (NVTA) prolonge la tendance à ..
08/09EN DIRECTO DESDE LOS MERCADOS : Sika, ByteDance, Renault, Logitech, PostNL, Aramco, Philip..
08/09MADRID STOCK EXCHANGE : Resultados casi perfectos
08/09STOCK MARKET PARIS : Des résultats presque parfaits
08/09EN DIRECT DES MARCHES : EDF, Renault, Atos, Rémy Cointreau, Logitech, PostNL, Aramco, Phil..
More news
Analyst Recommendations on INVITAE CORPORATION
More recommendations
Chart INVITAE CORPORATION
Duration : Period :
Invitae Corporation Technical Analysis Chart | NVTA | US46185L1035 | MarketScreener
Technical analysis trends INVITAE CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 31,73 $
Average target price 40,44 $
Spread / Average Target 27,5%
EPS Revisions
Managers and Directors
Sean Emerson George Chairman, President & Chief Executive Officer
Roxi Wen Chief Financial Officer
Robert Nussbaum Chief Medical Officer
Eric Olivares Chief Science Officer
Layton Wedgeworth Chief Technology Officer
Sector and Competitors